FTO (Freedom to Operate) in the Pharmaceutical Industry
FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to perfor...
Saved in:
| Hovedforfatter: | |
|---|---|
| Format: | Online |
| Sprog: | engelsk |
| Udgivet: |
Nomos Verlagsgesellschaft mbH & Co. KG
2021
|
| Fag: | |
| Online adgang: | 29406 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
| Summary: | FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to perform a good FTO search and conclude an appropriate FTO licensing agreement, and then points out two issues; (i) the issue of FTO licensing and EU competition, especially the unreasonable application of the Guideline, and (ii) the issue of FTO licensing and differentiating between a bio venture company and a pharmaceutical company. Solutions for these issues are proposed. |
|---|